SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001420720-22-000041
Filing Date
2022-06-14
Accepted
2022-06-14 16:01:34
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFR14A tmb-20220614xdefr14a.htm DEFR14A 115917
2 GRAPHIC tmb-20220614xdefr14a001.jpg GRAPHIC 6111
3 GRAPHIC tmb-20220614xdefr14a004.jpg GRAPHIC 206157
4 GRAPHIC tmb-20220614xdefr14a005.jpg GRAPHIC 162380
5 GRAPHIC tmb-20220614xdefr14a003.jpg GRAPHIC 6781
  Complete submission text file 0001420720-22-000041.txt   643013
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFR14A | Act: 34 | File No.: 001-35023 | Film No.: 221014688
SIC: 2834 Pharmaceutical Preparations